Skip to main content
Top
Published in: Pediatric Nephrology 2/2021

01-02-2021 | Obesity | Original Article

Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease

Authors: Vasiliki Karava, John Dotis, Antonia Kondou, Athanasios Christoforidis, Vassilios Liakopoulos, Konstantina Tsioni, Konstantinos Kollios, Fotios Papachristou, Nikoleta Printza

Published in: Pediatric Nephrology | Issue 2/2021

Login to get access

Abstract

Introduction

This cross-sectional study investigates the association between insulin resistance (IR) and serum uric acid (sUA) and relative fat (RFM) and lean mass (RLM) profiles in children with chronic kidney disease (CKD).

Material and methods

RLM and RFM were assessed by bioimpedance spectroscopy in 41 children and adolescents. Normal weight obesity (NWO) was defined as normal height-age body mass index and RFM >85th percentile, according to age and sex. Homeostatic model assessment of insulin resistance (HOMA-IR) level >95th percentile, according to sex and pubertal stage, and sUA >7 mg/dl were used to define IR and hyperuricemia, respectively.

Results

High RFM (15 patients) and NWO (7 patients) were associated with higher HOMA-IR in total (p < 0.001) and normal-weight patients (p = 0.004), respectively. RFM was positively and RLM negatively correlated to HOMA-IR (rs = 0.500, p = 0.001 and rs = −0.539, p < 0.001, respectively) and sUA (rs = 0.370, p = 0.017 and rs = −0.325, p = 0.038, respectively), while sUA was positively correlated to HOMA-IR (rs = 0.337, p = 0.031). Hyperuricemia (16 patients) was positively associated with higher RFM and HOMA-IR (p = 0.001 and p = 0.010, respectively). The correlation between sUA and HOMA-IR lost significance after adjustment for RFM. In logistic regression analysis, a 5% increase in RFM was associated with IR (11 patients) independently of the age, sex, sUA, and CKD stage in both total (OR 2.174, 95% CI 1.115–4.225) and normal-weight (OR 3.504, 95% CI 1.110–11.123) patients.

Conclusion

Children with high RFM, including those presenting NWO, are at risk for IR regardless of CKD stage. RFM is probably the mediator of the link between sUA and IR.
Literature
1.
go back to reference Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol 311:F1087–F1108CrossRef Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol 311:F1087–F1108CrossRef
2.
go back to reference Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRef Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRef
3.
go back to reference Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, Jensen MD, Parati G, Lopez-Jimenez F (2010) Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 31:737–746CrossRef Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, Jensen MD, Parati G, Lopez-Jimenez F (2010) Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 31:737–746CrossRef
4.
go back to reference Wiklund P, Törmäkangas T, Shi Y, Wu N, Vainionpää A, Alen M, Cheng S (2017) Normal-weight obesity and cardiometabolic risk: a 7-year longitudinal study in girls from prepuberty to early adulthood. Obesity (Silver Spring) 25:1077–1082CrossRef Wiklund P, Törmäkangas T, Shi Y, Wu N, Vainionpää A, Alen M, Cheng S (2017) Normal-weight obesity and cardiometabolic risk: a 7-year longitudinal study in girls from prepuberty to early adulthood. Obesity (Silver Spring) 25:1077–1082CrossRef
5.
go back to reference Sgambat K, Roem J, Mitsnefes M, Portale AA, Furth S, Warady B, Moudgil A (2018) Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease. Pediatr Nephrol 33:1577–1583CrossRef Sgambat K, Roem J, Mitsnefes M, Portale AA, Furth S, Warady B, Moudgil A (2018) Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease. Pediatr Nephrol 33:1577–1583CrossRef
6.
go back to reference Mak RH (2008) Insulin and its role in chronic kidney disease. Pediatr Nephrol 23:355–362CrossRef Mak RH (2008) Insulin and its role in chronic kidney disease. Pediatr Nephrol 23:355–362CrossRef
7.
go back to reference Weaver DJ Jr (2019) Uric acid and progression of chronic kidney disease. Pediatr Nephrol 34:801–809 Weaver DJ Jr (2019) Uric acid and progression of chronic kidney disease. Pediatr Nephrol 34:801–809
8.
go back to reference Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, Ritz E (2013) Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 28:2221–2228 Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, Ritz E (2013) Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 28:2221–2228
9.
go back to reference Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, Lanaspa MA, Nakagawa T, Johnson RJ (2016) Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med 29:3–8CrossRef Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, Lanaspa MA, Nakagawa T, Johnson RJ (2016) Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med 29:3–8CrossRef
10.
go back to reference Seyed-Sadjadi N, Berg J, Bilgin AA, Grant R (2017) Visceral fat mass: Is it the link between uric acid and diabetes risk? Lipids Health Dis 16:142CrossRef Seyed-Sadjadi N, Berg J, Bilgin AA, Grant R (2017) Visceral fat mass: Is it the link between uric acid and diabetes risk? Lipids Health Dis 16:142CrossRef
11.
go back to reference Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRef Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRef
12.
go back to reference Kurtoglu S, Mazicioglu MM, Ozturk A, Hatipoglu N, Cicek B, Ustunbas HB (2010) Body fat reference curves for healthy Turkish children and adolescents. Eur J Pediatr 169:1329–1335CrossRef Kurtoglu S, Mazicioglu MM, Ozturk A, Hatipoglu N, Cicek B, Ustunbas HB (2010) Body fat reference curves for healthy Turkish children and adolescents. Eur J Pediatr 169:1329–1335CrossRef
13.
go back to reference d'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, Lorini R, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes (2009) Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biomed 80:21–28PubMed d'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, Lorini R, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes (2009) Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biomed 80:21–28PubMed
14.
go back to reference Buyan N, Bideci A, Ozkaya O, Ortac E, Bakkaloglu S, Gonen S, Peru H, Soylemezoglu O, Cinaz P (2006) Leptin and resistin levels and their relationships with glucose metabolism in children with chronic renal insufficiency and undergoing dialysis. Nephrology (Carlton) 11:192–196 Buyan N, Bideci A, Ozkaya O, Ortac E, Bakkaloglu S, Gonen S, Peru H, Soylemezoglu O, Cinaz P (2006) Leptin and resistin levels and their relationships with glucose metabolism in children with chronic renal insufficiency and undergoing dialysis. Nephrology (Carlton) 11:192–196
15.
go back to reference Lai HL, Kartal J, Mitsnefes M (2007) Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-α. Pediatr Nephrol 22:1751–1756CrossRef Lai HL, Kartal J, Mitsnefes M (2007) Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-α. Pediatr Nephrol 22:1751–1756CrossRef
16.
go back to reference Canpolat N, Caliskan S, Sever L, Guzeltas A, Kantarci F, Candan C, Civilibal M, Kasapcopur O, Arisoy N (2012) Glucose intolerance: Is it a risk factor for cardiovascular disease in children with chronic kidney disease? Pediatr Nephrol 27:627–635CrossRef Canpolat N, Caliskan S, Sever L, Guzeltas A, Kantarci F, Candan C, Civilibal M, Kasapcopur O, Arisoy N (2012) Glucose intolerance: Is it a risk factor for cardiovascular disease in children with chronic kidney disease? Pediatr Nephrol 27:627–635CrossRef
17.
go back to reference Lindblad YT, Axelsson J, Bárány P, Celsi G, Lindholm B, Qureshi AR, Carrea A, Canepa A (2008) Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purif 26:518–525CrossRef Lindblad YT, Axelsson J, Bárány P, Celsi G, Lindholm B, Qureshi AR, Carrea A, Canepa A (2008) Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purif 26:518–525CrossRef
18.
go back to reference Patel HP, Saland JM, Ng DK, Jiang S, Warady BA, Furth SL, Flynn JT (2017) Waist circumference and body mass index in children with chronic kidney disease and metabolic, cardiovascular, and renal outcomes. J Pediatr 191:133–139CrossRef Patel HP, Saland JM, Ng DK, Jiang S, Warady BA, Furth SL, Flynn JT (2017) Waist circumference and body mass index in children with chronic kidney disease and metabolic, cardiovascular, and renal outcomes. J Pediatr 191:133–139CrossRef
19.
go back to reference Lalan S, Jiang S, Ng DK, Kupferman F, Warady BA, Furth S, Mitsnefes MM (2018) Cardiometabolic risk factors, metabolic syndrome, and chronic kidney disease progression in children. J Pediatr 202:163–170CrossRef Lalan S, Jiang S, Ng DK, Kupferman F, Warady BA, Furth S, Mitsnefes MM (2018) Cardiometabolic risk factors, metabolic syndrome, and chronic kidney disease progression in children. J Pediatr 202:163–170CrossRef
20.
go back to reference Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D, MMKD Study Group (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16:1091–1098CrossRef Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D, MMKD Study Group (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16:1091–1098CrossRef
21.
go back to reference Marlais M, Coward RJ (2015) Paediatrics, insulin resistance and the kidney. Pediatr Nephrol 30:1217–1224CrossRef Marlais M, Coward RJ (2015) Paediatrics, insulin resistance and the kidney. Pediatr Nephrol 30:1217–1224CrossRef
22.
go back to reference Manios Y, Moschonis G, Kourlaba G, Bouloubasi Z, Grammatikaki E, Spyridaki A, Hatzis C, Kafatos A, Fragiadakis GA (2008) Prevalence and independent predictors of insulin resistance in children from Crete, Greece: the children study. Diabet Med 25:65–72PubMed Manios Y, Moschonis G, Kourlaba G, Bouloubasi Z, Grammatikaki E, Spyridaki A, Hatzis C, Kafatos A, Fragiadakis GA (2008) Prevalence and independent predictors of insulin resistance in children from Crete, Greece: the children study. Diabet Med 25:65–72PubMed
23.
go back to reference Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N, Georgiou C, Kafatos A (2000) Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 24:1453–1458CrossRef Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N, Georgiou C, Kafatos A (2000) Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 24:1453–1458CrossRef
24.
go back to reference Blüher S, Molz E, Wiegand S, Otto KP, Sergeyev E, Tuschy S, L'Allemand-Jander D, Kiess W, Holl RW, Adiposity Patients Registry Initiative and German Competence Net Obesity (2013) Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab 98:3384–3393CrossRef Blüher S, Molz E, Wiegand S, Otto KP, Sergeyev E, Tuschy S, L'Allemand-Jander D, Kiess W, Holl RW, Adiposity Patients Registry Initiative and German Competence Net Obesity (2013) Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab 98:3384–3393CrossRef
25.
go back to reference Lin TY, Lim PS, Hung SC (2018) Normal-weight obesity and clinical outcomes in nondiabetic chronic kidney disease patients: a cohort study. Am J Clin Nutr 107:664–672 Lin TY, Lim PS, Hung SC (2018) Normal-weight obesity and clinical outcomes in nondiabetic chronic kidney disease patients: a cohort study. Am J Clin Nutr 107:664–672
26.
go back to reference Srikanthan P, Karlamangla AS (2011) Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 96:2898–28903CrossRef Srikanthan P, Karlamangla AS (2011) Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 96:2898–28903CrossRef
27.
go back to reference Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA (2007) Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71:146–152CrossRef Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA (2007) Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71:146–152CrossRef
28.
go back to reference Price SR, Gooch JL, Donaldson SK, Roberts-Wilson TK (2010) Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling. J Ren Nutr 20:S24–S28CrossRef Price SR, Gooch JL, Donaldson SK, Roberts-Wilson TK (2010) Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling. J Ren Nutr 20:S24–S28CrossRef
29.
go back to reference Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B (2019) Oxidative stress in chronic kidney disease. Pediatr Nephrol 34:975–991CrossRef Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B (2019) Oxidative stress in chronic kidney disease. Pediatr Nephrol 34:975–991CrossRef
30.
go back to reference Gondouin B, Jourde-Chiche N, Sallee M, Dou L, Cerini C, Loundou A, Morange S, Berland Y, Burtey S, Brunet P, Guieu R, Dussol B (2015) Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels. Nephron 131:167–174CrossRef Gondouin B, Jourde-Chiche N, Sallee M, Dou L, Cerini C, Loundou A, Morange S, Berland Y, Burtey S, Brunet P, Guieu R, Dussol B (2015) Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels. Nephron 131:167–174CrossRef
31.
go back to reference Kubota M (2019) Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab 2019:3480718CrossRef Kubota M (2019) Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab 2019:3480718CrossRef
32.
go back to reference Sakou II, Psaltopoulou T, Sergentanis TN, Karavanaki K, Karachaliou F, Ntanasis-Stathopoulos I, Tzanninis S, Sdogou T, Greydanus D, Tsitsika A (2015) Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach. J Pediatr Endocrinol Metab 28:589–596 Sakou II, Psaltopoulou T, Sergentanis TN, Karavanaki K, Karachaliou F, Ntanasis-Stathopoulos I, Tzanninis S, Sdogou T, Greydanus D, Tsitsika A (2015) Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach. J Pediatr Endocrinol Metab 28:589–596
33.
go back to reference Beavers KM, Beavers DP, Serra MC, Bowden RG, Wilson RL (2009) Low relative skeletal muscle mass indicative of sarcopenia is associated with elevations in serum uric acid levels: findings from NHANES III. J Nutr Health Aging 13:177–182CrossRef Beavers KM, Beavers DP, Serra MC, Bowden RG, Wilson RL (2009) Low relative skeletal muscle mass indicative of sarcopenia is associated with elevations in serum uric acid levels: findings from NHANES III. J Nutr Health Aging 13:177–182CrossRef
34.
go back to reference Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML (2003) Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42:474–480CrossRef Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML (2003) Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42:474–480CrossRef
35.
go back to reference Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI (2013) Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 62:392–399CrossRef Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI (2013) Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 62:392–399CrossRef
36.
go back to reference Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145–4151CrossRef Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145–4151CrossRef
37.
go back to reference De Oliveira EP, Burini RC (2012) High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 4:12CrossRef De Oliveira EP, Burini RC (2012) High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 4:12CrossRef
38.
go back to reference Ferrando B, Gomez-Cabrera MC, Salvador-Pascual A, Puchades C, Derbré F, Gratas-Delamarche A, Laparre L, Olaso-Gonzalez G, Cerda M, Viosca E, Alabajos A, Sebastiá V, Alberich-Bayarri A, García-Castro F, Viña J (2018) Allopurinol partially prevents disuse muscle atrophy in mice and humans. Sci Rep 8:3549CrossRef Ferrando B, Gomez-Cabrera MC, Salvador-Pascual A, Puchades C, Derbré F, Gratas-Delamarche A, Laparre L, Olaso-Gonzalez G, Cerda M, Viosca E, Alabajos A, Sebastiá V, Alberich-Bayarri A, García-Castro F, Viña J (2018) Allopurinol partially prevents disuse muscle atrophy in mice and humans. Sci Rep 8:3549CrossRef
39.
go back to reference Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, Shirakura T, Kato K, Imaizumi K, Takahashi H, Tamura M, Maeda N, Funahashi T, Shimomura I (2013) Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem 288:27138–27149 Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, Shirakura T, Kato K, Imaizumi K, Takahashi H, Tamura M, Maeda N, Funahashi T, Shimomura I (2013) Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem 288:27138–27149
40.
go back to reference Karava V, Printza N, Dotis J, Demertzi D, Antza C, Kotsis V, Papachristou F, Stabouli S (2019) Body composition and arterial stiffness in children with chronic kidney disease. Pediatr Nephrol 34:1253–1260 Karava V, Printza N, Dotis J, Demertzi D, Antza C, Kotsis V, Papachristou F, Stabouli S (2019) Body composition and arterial stiffness in children with chronic kidney disease. Pediatr Nephrol 34:1253–1260
41.
go back to reference Derbre F, Ferrando B, Gomez-Cabrera MC, Sanchis-Gomar F, Martinez-Bello VE, Olaso-Gonzalez G, Diaz A, Gratas-Delamarche A, Cerda M, Viña J (2012) Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases. PLoS One 7:e46668CrossRef Derbre F, Ferrando B, Gomez-Cabrera MC, Sanchis-Gomar F, Martinez-Bello VE, Olaso-Gonzalez G, Diaz A, Gratas-Delamarche A, Cerda M, Viña J (2012) Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases. PLoS One 7:e46668CrossRef
42.
go back to reference Sanchis-Gomar F, Pareja-Galeano H, Perez-Quilis C, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Lucia A (2015) Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches? Cell Stress Chaperones 20:3–13CrossRef Sanchis-Gomar F, Pareja-Galeano H, Perez-Quilis C, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Lucia A (2015) Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches? Cell Stress Chaperones 20:3–13CrossRef
43.
go back to reference Madero M, Rodríguez Castellanos FE, Jalal D, Villalobos-Martín M, Salazar J, Vazquez-Rangel A, Johnson RJ, Sanchez-Lozada LG (2015) A pilot study on the impact of a low fructose diet and allopurinol on clinic blood pressure among overweight and prehypertensive subjects: a randomized placebo controlled trial. J Am Soc Hypertens 9:837–844CrossRef Madero M, Rodríguez Castellanos FE, Jalal D, Villalobos-Martín M, Salazar J, Vazquez-Rangel A, Johnson RJ, Sanchez-Lozada LG (2015) A pilot study on the impact of a low fructose diet and allopurinol on clinic blood pressure among overweight and prehypertensive subjects: a randomized placebo controlled trial. J Am Soc Hypertens 9:837–844CrossRef
44.
go back to reference Soletsky B, Feig DI (2012) Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 60:1148–1156CrossRef Soletsky B, Feig DI (2012) Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 60:1148–1156CrossRef
45.
go back to reference Talma H, Chinapaw MJ, Bakker B, HiraSing RA, Terwee CB, Altenburg TM (2013) Bioelectrical impedance analysis to estimate body composition in children and adolescents: a systematic review and evidence appraisal of validity, responsiveness, reliability and measurement error. Obes Rev 14:895–905 Talma H, Chinapaw MJ, Bakker B, HiraSing RA, Terwee CB, Altenburg TM (2013) Bioelectrical impedance analysis to estimate body composition in children and adolescents: a systematic review and evidence appraisal of validity, responsiveness, reliability and measurement error. Obes Rev 14:895–905
46.
go back to reference Canpolat N, Caliskan S, Sever L, Tasdemir M, Ekmekci OB, Pehlivan G, Shroff R (2013) Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis. Pediatr Nephrol 28:2149–2156 Canpolat N, Caliskan S, Sever L, Tasdemir M, Ekmekci OB, Pehlivan G, Shroff R (2013) Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis. Pediatr Nephrol 28:2149–2156
47.
go back to reference Broers NJH, Canaud B, Dekker MJE, van der Sande FM, Stuard S, Wabel P, Kooman JP (2020) Three compartment bioimpedance spectroscopy in the nutritional assessment and the outcome of patients with advanced or end stage kidney disease: What have we learned so far? Hemodial Int 4:148–161CrossRef Broers NJH, Canaud B, Dekker MJE, van der Sande FM, Stuard S, Wabel P, Kooman JP (2020) Three compartment bioimpedance spectroscopy in the nutritional assessment and the outcome of patients with advanced or end stage kidney disease: What have we learned so far? Hemodial Int 4:148–161CrossRef
48.
go back to reference Milani GP, Groothoff JW, Vianello FA, Fossali EF, Paglialonga F, Consolo S, Edefonti A, Consonni D, van Harskamp D, van Goudoever JB, Schierbeek H, Agostoni C, Oosterveld MJS (2018) Bioimpedance spectroscopy imprecisely assesses lean body mass in pediatric dialysis patients. J Pediatr Gastroenterol Nutr 67:533–537CrossRef Milani GP, Groothoff JW, Vianello FA, Fossali EF, Paglialonga F, Consolo S, Edefonti A, Consonni D, van Harskamp D, van Goudoever JB, Schierbeek H, Agostoni C, Oosterveld MJS (2018) Bioimpedance spectroscopy imprecisely assesses lean body mass in pediatric dialysis patients. J Pediatr Gastroenterol Nutr 67:533–537CrossRef
Metadata
Title
Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease
Authors
Vasiliki Karava
John Dotis
Antonia Kondou
Athanasios Christoforidis
Vassilios Liakopoulos
Konstantina Tsioni
Konstantinos Kollios
Fotios Papachristou
Nikoleta Printza
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 2/2021
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-020-04716-y

Other articles of this Issue 2/2021

Pediatric Nephrology 2/2021 Go to the issue